Influenza Vaccine，Live，Nasal (Changchun Baike Biotechnology )

鼻喷流感减毒活疫苗（长春百克生物科技）

Report date: 2026/05/28 20:00:21

Base Information

Drug NameInfluenza Vaccine，Live，Nasal (Changchun Baike Biotechnology )
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanCommon Cold +[4] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2025/08/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Bcht Biotechnology Co
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanCommon Cold +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A